Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
C3I (United States)
h-index: 1
Total citations: 1
Total papers: 2
Homepage:
http://c3i-inc.com/
Recent papers from C3I (United States)
Dupilumab Efficacy on Exacerbations and Lung Function by Cough and Sputum Score: Pooled Results from Phase 3 BOREAS and NOTUS
ERJ Open Research · 2026
Experiences with Efanesoctocog Alfa: Exit Interviews with Caregivers of Previously Treated XTEND-Kids Phase III Trial Patients with Haemophilia A
Patient · 2026
Preserving beta cell function in children and adolescents with newly diagnosed stage 3 type 1 diabetes: per-protocol population analysis from the PROTECT randomised trial
Diabetologia · 2026
Causal Inference and Pathway Embeddings with Real-World Data for Enhanced Trial Design Across Diseases
Mathematical and Computational Applications · 2026
Patient-Reported Outcomes and Healthcare Provider Perspectives on Subcutaneous Isatuximab Delivery via On-Body Injector vs Manual Injection: Results From the Phase 2 IZALCO Study in Relapsed/Refractory Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia · 2026
Quantitative Systems Pharmacology (QSP): Bridging Biology and Mechanism with Clinical Drug Development Decisions
The Journal of Clinical Pharmacology · 2026
High-dose vs. standard-dose influenza vaccine in heart failure: the FLUNITY-HD trial
European Heart Journal · 2026
Emerald Touchless Sensor Quantifies Nighttime Scratching and Sleep Quality in Children With Atopic Dermatitis: PEDISTAD EMERALD Study
Dermatology and Therapy · 2026
Belumosudil achieves clinical response in chronic graft-versushost disease with varying organ-specific response kinetics: an analysis from the phase II ROCKstar trial
Haematologica · 2026
Delineating a reference interval for functional alpha-1 antitrypsin in the serum of healthy Pi*MM donors using an anti-neutrophil elastase capacity assay
Respiratory Research · 2026
Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Moderate-to-Severe Asthma, Type 2 Inflammation, and Nocturnal Awakenings: The MORPHEO Randomized Controlled Trial
Journal of Investigational Allergology and Clinical Immunology · 2026
Effectiveness and safety of interleukin 6 receptor inhibitors versus conventional immunomodulatory therapy in steroid-refractory polymyalgia rheumatica
RMD Open · 2026
Dupilumab effectiveness and safety in patients with chronic rhinosinusitis with nasal polyps
Annals of Allergy Asthma & Immunology · 2026
Dupilumab for patients with allergic fungal rhinosinusitis
Journal of Allergy and Clinical Immunology · 2026
A phase 2 trial of rilzabrutinib in IgG4-related disease
Annals of the Rheumatic Diseases · 2026
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial
The Lancet. Gastroenterology & hepatology · 2026
Efficacy and Safety of Frexalimab in Participants With Relapsing Multiple Sclerosis: 3-Year Results From the Phase 2 Open-label Extension (P7-19.003)
Neurology · 2026
Baseline Characteristics of Patients with Asthma Initiating Dupilumab in a Real-World Setting: The REVEAL Registry
Advances in Therapy · 2026
Effect of Dupilumab on Airway Inflammation in Patients With Persistent Asthma
Allergy · 2026
Safety and reliability of isatuximab subcutaneous on-body injector: Results across the phase 3 IRAKLIA, phase 2 IZALCO and phase 1b TCD15484 trials.
Journal of Clinical Oncology · 2026